NCT01066663 2023-02-22Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDana-Farber Cancer InstitutePhase 1/2 Completed20 enrolled 9 charts